gemfibrozil has been researched along with Demyelinating Diseases in 1 studies
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jana, M | 1 |
| Mondal, S | 1 |
| Gonzalez, FJ | 1 |
| Pahan, K | 1 |
1 trial available for gemfibrozil and Demyelinating Diseases
| Article | Year |
|---|---|
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.
Topics: Animals; Cells, Cultured; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Gemfi | 2012 |